Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Deferred Taxes (2019 - 2025)

Health Catalyst (HCAT) has disclosed Deferred Taxes for 7 consecutive years, with $43000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Deferred Taxes rose 108.07% year-over-year to $43000.0, compared with a TTM value of $480000.0 through Sep 2025, up 193.2%, and an annual FY2024 reading of $77000.0, up 862.5% over the prior year.
  • Deferred Taxes was $43000.0 for Q3 2025 at Health Catalyst, up from -$224000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $594000.0 in Q4 2024 and bottomed at -$6.8 million in Q3 2021.
  • Average Deferred Taxes over 5 years is -$615052.6, with a median of $2000.0 recorded in 2021.
  • The sharpest move saw Deferred Taxes tumbled 180000.0% in 2022, then soared 29600.0% in 2024.
  • Year by year, Deferred Taxes stood at -$311000.0 in 2021, then skyrocketed by 101.29% to $4000.0 in 2022, then crashed by 50.0% to $2000.0 in 2023, then skyrocketed by 29600.0% to $594000.0 in 2024, then plummeted by 92.76% to $43000.0 in 2025.
  • Business Quant data shows Deferred Taxes for HCAT at $43000.0 in Q3 2025, -$224000.0 in Q2 2025, and $67000.0 in Q1 2025.